RxDoctor Payments Data

Taylor Monaghan, PA

Physician Assistant · Tulsa, OKNPI 1326680570

Payments from drug & device makers

$2,358in general payments, 2019–2025

Across 87 payments — averaging $27.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$336
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$316
  • E.r. Squibb & Sons, L.L.C.$235
  • Philips North America LLC$220
  • Abbott$193
  • Atricure, Inc.$192
  • plus $866 from 15 others

What the payments were for

  • Food & beverage$2,34099%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,358 in reported general payments places this provider in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$51,622
Medicare patients
486
Services billed
684

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban718$628,341
XareltoRivaroxaban110$112,570
MultaqDronedarone Hcl15$18,357
Flecainide Acetate223$8,072
Amiodarone Hcl205$5,696
Metoprolol Succinate227$4,475
Metoprolol Tartrate165$1,165
Diltiazem 24hr Er (Cd)Diltiazem Hcl41$1,075
SotalolSotalol Hcl42$596
Carvedilol70$400
Digoxin15$376
Losartan Potassium42$347
Diltiazem Hcl24$335
Lisinopril35$273
Diltiazem 24hr ErDiltiazem Hcl16$270

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$169$628,341718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,491 physician assistant providers in Oklahoma.

Other physician assistant in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →